直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Accord Healthcare, Inc. v. Helsinn Healthcare, S.A.

Accord Healthcare, Inc.

Helsinn Healthcare, S.A.

Represented Helsinn in first-ever PGR dealing with pharmaceuticals, which settled prior to institution determination. Represented Helsinn as the patent owner in two PGRs denied by PTAB, and in several IPRs that all settled prior to a determination of institution.

Accord Healthcare, Inc. v. Helsinn Healthcare, S.A., PGR2014-00010, PTAB, Judges Green, Snedden, Tornquist

Related Practices

Global IP Enforcement, Litigation, and Trials

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Siemens Healthcare Diagnostics Inc. v. Radiometer Medical ApS

Radiometer Medical ApS

Aventis Pharma, S.A. v. Baxter Healthcare Corp.

Aventis Pharma, S.A.

Accord Healthcare Limited & Ors v. The Regents of the University of California & Astellas Pharma Europe Ltd.*

The Regents of the University of California & Astellas Pharma Europe Ltd.

Wyeth v. Cadila Healthcare Limited and Zydus Pharmaceuticals (USA) Inc.

Wyeth

Full intellectual property service for a healthcare client developing wireless communication systems

Advised a global healthcare company in anticipated court proceedings seeking declarations of non-infringement related to its influenza vaccines*

Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia*

Advised a consumer-focused private investment firm on healthcare regulatory aspects of its definitive agreement to acquire a majority stake in a skin barrier and skin health brand*

Advised two leading middle market private equity firms on healthcare regulatory aspects of a definitive agreement to acquire a medical equipment manufacturing company*

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP